{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:07:18Z","timestamp":1774332438188,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009128","name":"Research for Patient Benefit Programme","doi-asserted-by":"publisher","award":["PB-PG-0712-28094"],"award-info":[{"award-number":["PB-PG-0712-28094"]}],"id":[{"id":"10.13039\/501100009128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jpurol.2020.10.012","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T01:57:08Z","timestamp":1603072628000},"page":"77.e1-77.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Onabotulinum toxin-A versus extended release tolterodine in the management of idiopathic overactive bladder in children: A pilot randomised controlled trial (OVERT trial)"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7772-271X","authenticated-orcid":false,"given":"Michaela","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula R.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3327-5927","authenticated-orcid":false,"given":"Laura","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Melling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.A.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anju","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpurol.2020.10.012_bib1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2165\/00148581-200709060-00005","article-title":"Pediatric overactive bladder syndrome: pathophysiology and management","volume":"9","author":"Franco","year":"2007","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jpurol.2020.10.012_bib2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1542\/peds.113.2.334","article-title":"Coping, commitment, and attitude: quantifying the everyday burden of enuresis on children and their families","volume":"113","author":"Landgraf","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpurol.2020.10.012_bib3","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1464-410X.2010.09993.x","article-title":"Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction","volume":"108","author":"Irwin","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.jpurol.2020.10.012_bib4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1464-410X.2008.08036.x","article-title":"The economic impact of overactive bladder syndrome in six Western countries","volume":"103","author":"Irwin","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.jpurol.2020.10.012_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.urology.2008.06.063","article-title":"Prevalence and associated factors of overactive bladder in Korean children 5-13 years old: a nationwide multicenter study","volume":"73","author":"Chung","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2020.10.012_bib6","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1651-2227.1996.tb18232.x","article-title":"Enuresis: prevalence and associated factors among primary school children in Saudi Arabia","volume":"85","author":"Kalo","year":"1996","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jpurol.2020.10.012_bib7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1464-410X.2005.05640.x","article-title":"Nocturnal enuresis at 7.5 years old: prevalence and analysis of clinical signs","volume":"96","author":"Butler","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.jpurol.2020.10.012_bib8","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/00004583-200012000-00020","article-title":"Attaining nocturnal urinary control, nocturnal enuresis, and behavioral problems in Chinese children aged 6 through 16 years","volume":"39","author":"Liu","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jpurol.2020.10.012_bib9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nrurol.2016.152","article-title":"Overactive bladder in children","volume":"13","author":"Franco","year":"2016","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.jpurol.2020.10.012_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.urology.2009.06.100","article-title":"Intractable voiding dysfunction in children with normal spinal imaging: predictors of failed conservative management","volume":"75","author":"Stone","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2020.10.012_bib11","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0022-5347(05)00416-7","article-title":"Childhood urinary symptoms predict adult overactive bladder symptoms","volume":"175","author":"Fitzgerald","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2020.10.012_bib12","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.urology.2005.11.060","article-title":"Frequency of wetting is predictive of response to anticholinergic treatment in children with overactive bladder","volume":"67","author":"Van Arendonk","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2020.10.012_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.eururo.2016.02.007","article-title":"Prospective pilot study of mirabegron in pediatric patients with overactive bladder","volume":"70","author":"Blais","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpurol.2020.10.012_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00383-008-2260-3","article-title":"Botulinum toxin in paediatric urology: a systematic literature review","volume":"25","author":"DasGupta","year":"2009","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.jpurol.2020.10.012_bib15","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jpurol.2012.08.011","article-title":"Intravesical botulinum type-A toxin (Dysport(R)) in the treatment of idiopathic detrusor overactivity in children","volume":"9","author":"Blackburn","year":"2013","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.jpurol.2020.10.012_bib16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-5347(06)00301-6","article-title":"The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor","volume":"176","author":"Hoebeke","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2020.10.012_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-0029-1246193","article-title":"Effectiveness of botulinum-A toxin for the treatment of refractory overactive bladder in children","volume":"20","author":"Marte","year":"2010","journal-title":"Eur J Pediatr Surg"},{"key":"10.1016\/j.jpurol.2020.10.012_bib18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/00365599.2011.590997","article-title":"Urodynamic assessment of children treated with botulinum toxin A injections for urge incontinence: a pilot study","volume":"45","author":"Lahdes-Vasama","year":"2011","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.jpurol.2020.10.012_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00383-011-3039-5","article-title":"Urinary incontinence in children: botulinum toxin is a safe and effective treatment option","volume":"28","author":"McDowell","year":"2012","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.jpurol.2020.10.012_bib20","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.jpedsurg.2014.04.004","article-title":"Botulinum toxin injections in the management of non-neurogenic overactive bladders in children","volume":"49","author":"Leon","year":"2014","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jpurol.2020.10.012_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jpedsurg.2018.05.012","article-title":"Objective and subjective improvement in children with idiopathic detrusor overactivity after intravesical botulinum toxin injection: a preliminary report","volume":"54","author":"Al Edwan","year":"2019","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jpurol.2020.10.012_bib22","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0022-5347(06)00305-3","article-title":"The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society","volume":"176","author":"Neveus","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2020.10.012_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/nau.22751","article-title":"The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children's Continence Society","volume":"35","author":"Austin","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.jpurol.2020.10.012_bib24","series-title":"The NEWT guidelines for administration of medication to patients with enteral feeding tubes or swallowing difficulties","author":"Smyth","year":"2010"},{"key":"10.1016\/j.jpurol.2020.10.012_bib25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations","volume":"39","author":"Varni","year":"2001","journal-title":"Med Care"},{"key":"10.1016\/j.jpurol.2020.10.012_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jpurol.2005.07.004","article-title":"PinQ: a valid, reliable and reproducible quality-of-life measure in children with bladder dysfunction","volume":"2","author":"Bower","year":"2006","journal-title":"J Pediatr Urol"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513120305696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513120305696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:49:12Z","timestamp":1761486552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513120305696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1477513120305696"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2020.10.012","relation":{},"ISSN":["1477-5131"],"issn-type":[{"value":"1477-5131","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Onabotulinum toxin-A versus extended release tolterodine in the management of idiopathic overactive bladder in children: A pilot randomised controlled trial (OVERT trial)","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2020.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}